
浏览全部资源
扫码关注微信
重庆市第九人民医院药剂科
纸质出版日期:2009,
扫 描 看 全 文
[1]何雄伟.泽泻对健康受试者血脂影响的临床对照研究[J].重庆医科大学学报,2009,34(03):376-378.
HE Xiong-wei. The clinical control study on the effect of rhizoma alismatis on blood fat in health volunteers[J]. Journal of Chongqing Medical University, 2009,34(3):376-378.
目的:探讨泽泻对不同类型的健康人群血脂的影响。方法:实验于2007年1月
2
007年12月在重庆市第九人民医院完成。受试者26例
均为正常的健康人群。26名受试者服用泽泻颗粒
国食健字G20040383
上海生化科技开发中心提供
主要成分为泽泻
5g/袋
每日早晚各1次
1袋/次
2周为1个疗程
服用2个疗程。分别于服药前、服药后2周和4周后采血
采用日立7600自动生化分析仪依次检测血清蛋白胆固醇、载脂蛋白A、载脂蛋白B。分别探讨50岁以下受试者服用泽泻颗粒前后血脂变化和50岁以上受试者服用泽泻前后血脂变化。结果:50岁以下受试者服药2周后
三酰甘油水平有降低趋势
总胆固醇、低密度脂蛋白胆固醇水平与服药前相比
差异有显著性(P
<
0.01)
载脂蛋白A、载脂蛋白B、高密度脂蛋白胆固醇无变化;服药4周后
三酰甘油水平有降低趋势
总胆固醇、低密度脂蛋白胆固醇、载脂蛋白B水平与服药前相比。差异有显著性(P
<
0.01)
载脂蛋白A、高密度脂蛋白胆固醇无变化。50岁以上受试者服药2周后
总胆固醇水平有降低趋势
三酰甘油降低较明显
三酰甘油、低密度脂蛋白胆固醇水平与服药前相比
差异有显著性(P
<
0.05);载脂蛋白B比服药前降低明显
差异有显著性(P
<
0.01)
载脂蛋白A、高密度脂蛋白胆固醇无变化;4周后结果与2周后结果相同。结论:泽泻能有效降低健康人总胆固醇、载脂蛋白B、低密度脂蛋白胆固醇水平。
Objective:To discuss the effect of Rhizoma Alismatis on blood fat in different health volunteers. Methods:The experiment wasfinished in NO.9 People’s Hospital of Chongqing
from January 2007 to December 2007. 26 subjects were all healthy people. The 26 sub-jects took Rhizoma Alismatis granula(national food health product No.:G20040383
provided by the biochemistry technology development center of Shanghai). The essential component was Rhizoma Alismatis
5 g/pouch
taken once every morning and night
one pouch once time for two weeks as a course of treatment
two courses. Blood was drawn from the volunteers under the age of 50 years and above the age of 50 years before and after medication for two and four weeks
respectively. Serum protein cholesterol
apoprotein A
apoprotein B were detected by Hitachi 7 600 automatic biochemistry analyzer. Results:In the volunteers under the age of 50 years
the level of triacylglycerol had a down tendency after 2 week medication. Compared with that before medication
the level of total cholesterol and low density lipoprotein cholesterol had significant difference (P<0.01)
with no change in apoprotein A
apoprotein B and high density lipoprotein cholesterol. After four week medication
the level of triacylglycerol had a down tendency. Compared with that before medication
the level of total cholesterol
lowdensity lipoprotein cholesterol and apoprotein B had significant difference(P<0.01)
with no change in apoproatein A and high density lipoprotein cholesterol. In the volunteers above the age of 50 years
after two weeks of medication
the level of total cholesterol had a down tendency
and triacylglycerol had a remarkable decrease. Compared with that before medication
the level of triacylglycerol and low density lipoprotein cholesterol had significant difference(P<0.05). Apoprotein B had a noticeable decrease
with significant difference(P<0.01)compared with that before medication. Apoproatein A and high density lipoprotein cholesterol had no change. The results after four weeks and two weeks of medication were the same. Conclusion:Rhizoma Alismatis could reduce the level of total cholesterol
apoprotein B and lowdensity lipoprotein cholesterol for healthy people.
泽泻健康人群总胆固醇载脂蛋白B低密度脂蛋白胆固醇
0
浏览量
175
下载量
1
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621